A sophisticated approach to microcap investing mirrors private equity by becoming a 'value-added investor.' This involves taking a significant position and actively advising management on capital markets and strategy. The goal is to be a multiplier for the business, which provides fulfillment beyond just financial returns.

As an investor's capital grows in an illiquid space like micro-caps, they must hold positions longer or diversify. An extended duration forces a shift in focus from short-term plays to higher-quality businesses capable of sustained performance over time.

Some companies execute a 3-5 year plan and then revert to average returns. Others 'win by winning'—their success creates new opportunities and network effects, turning them into decade-long compounders that investors often sell too early.

Evidence-based research showed that the vast majority (around 90%) of micro-cap stocks that experience a 60% drawdown do not recover. This highlights the danger of averaging down in this asset class, as investors are often throwing good money after bad into fundamentally broken situations.

Unlike large-cap 'buy and hold' strategies, microcaps are fragile small businesses with high concentration risks (customer, management, geography). Investor Ian Cassel argues they have short 'winning seasons.' The key question isn't 'is this a good company?' but 'how long can this winning streak last?'—which is usually shorter than you think.

Contrary to the belief that a moat always leads to large-cap status, small-cap moats often protect a profitable niche. The moat provides time and protection for management to operate, but the "castle" itself may have a limited growth runway, focusing on returns within a specific market.

Contrary to the 'buy and hold forever' mantra, the fragile nature of microcap businesses means most should be 'rented,' not owned long-term. Due to risks like customer concentration, the average hold period is often around one year, as very few companies prove worthy of holding for extended periods.

The typical 'buy and hold forever' strategy is riskier than perceived because the median lifespan of a public company is just a decade. This high corporate mortality rate, driven by M&A and failure, underscores the need for investors to regularly reassess holdings rather than assume longevity.

The landscape for US microcap investing has fundamentally changed. High-quality companies, like a 1970s Walmart, no longer go public as microcaps due to regulations and private capital availability. Today's microcap universe is largely composed of 'fallen angels' or picked-over companies, requiring a more discerning approach.